Monthly Archives: October 2021
News
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in...
The European Commission has authorised ViiV Healthcare's Vocabria (cabotegravir long-acting injections) in combination with Johnson & Johnson’s Rekambys (rilpivirine long-acting injections) for the treatment of HIV-1 infection in...
U.S. FDA approves Celltrion’s AVTOZMA, a biosimilar to ACTEMRA
The U.S. Food and Drug Administration (FDA) has approved Celltrion's AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a...
hVIVO signs RSV human challenge trial contract with Inhalon Biopharma
hVIVO, a specialist contract research organisation (CRO), has signed a contract with Inhalon Biopharma, a clinical-stage company advancing a first-in-class inhaled antibody platform for...
